Rheumatology Flashcards

1
Q

If you wish to use NSAID in a patient with osteoarthritis what can be done to guard against GI problems?

A
  1. Add misoprostol
  2. Add PPI or H2 blocker
  3. Switch to Cox-2
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Most common symptom in osteoarthritis?

A
  • pain

- pain relief is the primary objective

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What do NSAIDs and ASA affect?

A

cyclooxygenase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

1st line treatment for osteoarthritis

A

Acetaminophen 4g/day

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

2nd line treatment for osteoarthritis

A

topical or oral NSAID

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the uses/benefits of using Choline and magnesium trisalicylate?

A

strategy to reduce GI toxicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Topical NSAID of choice in patient over 75

A

Ketoprofen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

If patient is over 75 years old, what is the first line agent for hand osteoarthritis?

A

Oral NSAIDs, Topical NSAIDs

or

topical capsaicin +/- tramadol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

If patient is over 75 with hand arthritis what is the 2nd line treatment

A

Combination: topical NSAID with tramadol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Goal of RA treatment

A

Achieve remission or low disease activity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

When should disease modifying antirheumatic drugs be started in RA?

A

within the first 3 months of diagnosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What function do NSAIDs and corticosteroids have on RA disease?

A

adjunctive therapy for symptom relief.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What can be done if one DMARD is not adequate?

A
  1. combination of DMARDS (ex. methotrexate and plaquenil)

2. DMARD + biologic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Non biologic DMARDs

A
  • methotrexate*
  • leflunomide
  • hydroxychloroquine
  • sulfasalazine
  • minocycline
  • Tofacitinib (kinase inhibitor)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Anti-TNF drugs

A
  • Entanercept (Enbrel)
  • infliximab (Remicade)
  • adalimumab (Humira)
  • certolizumab (Cimzia)
  • golimumab (Simponi)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Non-TNF drugs

A
  • abatacept
  • tocilizumab (IL-6)
  • Rituximab (peripheral B cell depletion)
  • Anakinra (IL-1)
17
Q

If triple drug therapy is needed, what does the ACR recommend?

A

Methotrexate + hydroxychloroquine + sulfasalazine

18
Q

Early vs. established RA

A

early is <6 months

established is >6 months

19
Q

Methotrexate: Toxicities

A

Hematologic - thrombocytopenia (CBC)

Pulmonary fibrosis (Xray)

Hepatic - elevated AST, ALT

Stomatitis*

20
Q

Leflunomide

A

MOA: decreases lymphocyte proliferation

Contraindicated: pregnancy, liver disease

Toxicities: bone marrow toxicity

21
Q

Hydroxychloroquine

A

-NOT myelosuppressive (like leflunomide)

  • Hepatic and renal toxicities
  • Ocular** (visual changes decrease in night or peripheral vision)
22
Q

Sulfasalazine

A

-Prodrug cleaved in colon (2 active metabolites after passing through the liver)

ADEs:

  • Elevated ALT, AST
  • May turn skin yellow-orange color* (no clinical significance)
  • Binds iron supplements decreasing absorption of sulfazalazine**
23
Q

Minocycline

A

-Tetracycline antibiotic derivative

-

24
Q

Tofacitinib

A
  • Use in moderate to severe disease in pt. who has failed methotrexate
  • Tyrosine kinase inhibitor
  • No live vaccines if taking this medication**
25
Q

TNF-alpha biologics

A

infliximab, etanercept, adalimumab

contraindications: CHF
ADE: MS-like illness, exacerbate MS
increased risk of lymphoproliferative cancer

26
Q

Which biologic depletes peripheral b cells

A

rituximab

27
Q

Infliximab

A
  • Chimeric antibody (human and mouse)

- Must be given with Methotrexate to prevent antibody formation

28
Q

Adalimumab

A

-human IgG antibody to TNF

29
Q

Anakinra (Kineret)

A
  • IL-1
  • MOA: affects T-cell proliferation and activation
  • Don’t give live vaccines
30
Q

Tocilizumab

A
  • IL-6

- avoid live vaccines

31
Q

How often can corticosteroids be injected?

A

every 3 months

MAX of 2-3 a year in same joint